CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $291 | -69.8% | 7,600 | -81.8% | 0.00% | 0.0% |
| Q1 2023 | $963 | +164.6% | 41,700 | +200.0% | 0.00% | -50.0% |
| Q4 2022 | $364 | -99.9% | 13,900 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $273,000 | +284.5% | 13,900 | +239.0% | 0.00% | – |
| Q2 2022 | $71,000 | -31.1% | 4,100 | -43.8% | 0.00% | – |
| Q2 2021 | $103,000 | +110.2% | 7,300 | +128.1% | 0.00% | – |
| Q1 2021 | $49,000 | -2.0% | 3,200 | 0.0% | 0.00% | – |
| Q4 2020 | $50,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |